BMAL1 and colitis: However, we found that upon DSS treatment, Bmal1 cKO mice exhibited a resistance to DSS-induced colitis, as evidenced by less weight loss, more intact epithelial barrier structure and function, as well as less infiltration of inflammatory factors and immune cells compared to control mice.